ISSCR News
The ISSCR Provides Comments on FNIH’s Accelerating Medicines Partnership Cell-Based Therapy Initiative
On 25 September 2023, the ISSCR submitted comments in response to the Foundation for National Institutes of Health’s (FNIH) Request for Information on Cell-Based Therapies for use in developing an Accelerating Medicines Partnership (AMP) Cell-Based Therapy Consortium.
The ISSCR Submits Comments on New National Science Foundation Technology Directorate
On 27 July 2023, the ISSCR submitted comments in response to a Request for Information on Developing a Roadmap for the Directorate for Technology, Innovation, and Partnerships (TIP) at the National Science Foundation, in accordance with the CHIPS and Science Act of 2022. This legislation tasks the TIP Directorate with developing a roadmap to guide investment decisions in use-inspired and translational research over a 3-year time frame, working towards the goal of advancing U.S. competitiveness in the identified key technology focus areas and addressing the identified societal, national, and geostrategic challenges.
The ISSCR Files Amicus Brief Supporting FDA’s Authority to Regulate Unproven Stem Cell-Based Interventions
The International Society for Stem Cell Research (ISSCR) filed an amicus curiae brief today to support the U.S. government’s appeal in U.S. v. California Stem Cell Treatment Center, Inc., a case that ruled the Food and Drug Administration (FDA) cannot regulate dangerous unproven stem cell-based interventions.
ISSCR Members Advocate for Stem Cell Research at 2023 U.S. Congressional Advocacy Day
On 2 March, the International Society for Stem Cell Research (ISSCR) led a delegation of 20 members from across the U.S. to Capitol Hill to advocate for the importance of fetal tissue research, increased funding for the National Institutes of Health (NIH), and the potential of chimeric embryo research.
ISSCR Joins Coalition Letter to Support 5% Increase in NIH Funding for FY 2024
The ISSCR is among 373 members of the Ad Hoc Group for Medical Research who signed a joint letter in support robust funding for the National Institutes of Health (NIH). For fiscal year (FY) 2024, the Ad Hoc Group recommends at least $50.924 billion for NIH’s foundational work, a $3.465 billion increase over the comparable FY 2023 program level.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .